CFA
IRWD icon

Cahill Financial Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Cahill Financial Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-219
Closed -$3K – 487
2021
Q3 		$3K Buy
+219
New +$2.83K ﹤0.01% 751

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Cahill Financial Advisors's IRWD Position: Q4 2021 in Review

Cahill Financial Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2021, closing a stake of 219 shares — an estimated $3K sold.

Cahill Financial Advisors first reported a position in IRWD in Q3 2021 and held it in 1 quarter. The position peaked at $3K in Q3 2021. 212 funds tracked by Wall St. Rank hold IRWD as of Q4 2021.

  • Cahill Financial Advisors reported no remaining Ironwood Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Cahill Financial Advisors sold 219 Ironwood Pharmaceuticals shares in Q4 2021, an estimated $3K.
  • Cahill Financial Advisors first reported a position in Ironwood Pharmaceuticals in Q3 2021 and held it in 1 quarter.
  • Cahill Financial Advisors's Ironwood Pharmaceuticals position peaked at $3K in Q3 2021.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2021.

Based on Cahill Financial Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.